Skip to main content
. Author manuscript; available in PMC: 2018 Apr 21.
Published in final edited form as: Cancer Invest. 2017 Mar 8;35(4):277–287. doi: 10.1080/07357907.2017.1289218

Table 1.

Demographic, anthropometric, and fruit and vegetable consumption by treatment group at baseline.

Group
p value
Intervention (n = 35) Control (n = 34)
Racea
 European-American 24 (69%) 25 (74%) .65
 African-American 11 (31%) 9 (26%)
Married/living with partnera
 Yes 25 (71%) 18 (56%) .20
 No 10 (29%) 14 (44%)
Educationa
 ≤High school 7 (20%) 8 (24%) .72
 >High school 28 (80%) 26 (76%)
Employment statusa
 Full time 13 (37%) 14 (45%) .78
 Part-time 6 (17%) 4 (13%)
 Unemployed 16 (46%) 13 (42%)
Participation in sportsa
 Yes 31 (89%) 29 (91%) .99
 No 4 (11%) 3 (9%)
Breast cancer statusa
 History of breast cancer 10 (29%) 10 (29%) .94
 No history of breast cancer 25 (71%) 24 (71%)
Ageb 60.3 ± 8.7 61.9 ± 8.7 .44
Body Mass Indexb 29.3 ± 5.0 28.8 ± 6.3 .69
Percentage of body fatb 40.1 ± 4.9 38.9 ± 6.2 .41
Total cruciferous vegetable intake (srv/d)b 0.42 ± 0.5 0.64 ± 0.7 .24
Total vegetables intake (srv/d)b 2.79 ± 1.0 3.32 ± 1.6 .10
Total fruit intake (srv/d)b 1.67 ± 1.1 1.61 ± 1.3 .83
Total vegetable and fruit intake (srv/d)b 4.47 ± 1.6 4.94 ± 2.4 .33
8-iso-PGFα (pg/mL)c 1394 ± 1491 1006 ± 799 .66
8oxodG (ng/mL)c 4.78 ± 4.56 4.96 ± 4.84 .86
a

Frequency (%), p value based on Chi-square or Fisher’s Exact test.

b

Mean ± standard deviation, p value based on t-tests.

c

Mean ± standard deviation, p value based on the Wilcoxon rank sums test.